Novartis Faces Another Challenge To Entresto In India

Torrent Seeks Patent Revocation

More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.

Intellectual Property law books and a gavel on desk in the library. concept of legal education.
Novartis Seeks To Block Torrent In Entresto Case • Source: Shutterstock

Novartis AG has hauled Torrent Pharmaceuticals Ltd. to court in India over the alleged infringement of a patent pertaining to its blockbuster heart failure therapy Entresto (sacubitril/valsartan).

The Swiss multinational, however, appears to be facing a parallel challenge with the Indian firm moving the country’s Intellectual Property...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia